ProSciento is the leading specialty clinical research organization (CRO) exclusively focused on diabetes, NASH, obesity and related metabolic diseases. Building on nearly two decades of experience and more than 350 metabolic clinical trials conducted, ProSciento provides customized clinical research services for multinational, early development clinical trial programs designed to give our clients an advantage in today’s rapidly evolving landscape of metabolic drug and device development. For more information, please visit www.prosciento.com Phone: (619) 427-1300 x100 Email: bd@prosciento.com